Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1

por Tseng, Jui-Cheng, Wei, James Cheng-Chung, Deodhar, Atul, Martin, Ruvie, Porter, Brian, McCreddin, Suzanne, Talloczy, Zsolt
Publicado 2020